- 专利标题： Antitumor peptide and use thereof
-
申请号： US16665101申请日： 2019-10-28
-
公开(公告)号： US11505589B2公开(公告)日： 2022-11-22
- 发明人: Nahoko Baileykobayashi , Tetsuhiko Yoshida , Makoto Sawada
- 申请人： TOAGOSEI CO., LTD. , National University Corporation Nagoya University
- 申请人地址： JP Tokyo; JP Aichi-ken
- 专利权人： TOAGOSEI CO., LTD.,National University Corporation Nagoya University
- 当前专利权人： TOAGOSEI CO., LTD.,National University Corporation Nagoya University
- 当前专利权人地址： JP Tokyo; JP Aichi-ken
- 代理机构： Occhiuti & Rohlicek LLP
- 优先权： JPJP2018-210913 20181108,JPJP2019-135840 20190724
- 主分类号： C07K14/705
- IPC分类号： C07K14/705 ; C07K14/47 ; A61P35/00 ; A61K38/00
摘要：
An antitumor peptide provided according to the present invention includes
(1) an S1PR-TM related sequence; and
(2) an amino acid sequence functioning as a cell penetrating peptide;
wherein the total number of amino acid residues is 100 or less.
(1) an S1PR-TM related sequence; and
(2) an amino acid sequence functioning as a cell penetrating peptide;
wherein the total number of amino acid residues is 100 or less.
公开/授权文献
- US20200148740A1 ANTITUMOR PEPTIDE AND USE THEREOF 公开/授权日：2020-05-14
信息查询
